P1.04-41 Immunotherapy Concomitant to Radiotherapy: A Multicentric Retrospective Study on 179 Patients with Advanced Non-Small Cell Lung Cancer

Immunotherapy (IT) has enhanced the treatment armamentarium for aNSCLC. Radiobiological studies and initial clinical reports suggest a potential synergistic effect of radiotherapy (RT) and IT. Aim of the study is to investigate the safety of cytoreductive RT (palliative or ablative) delivered in association with Nivolumab (NIVO), Pembrolizumab (PEM) or Atezolizumab (ATE) in aNSCLC setting. We analyzed 179 consecutive pts affected by aNSCLC...